A Comparison of Ureteroscopic Treatment of Nephrolithiasis With and Without Moses Technology
Overview
Tab Title Description
Study type
InterventionalDescribes the nature of a clinical study. Types include:
- Observational study — observes people and measures outcomes without affecting results.
- Interventional study (clinical trial) — studies new tests, treatments, drugs, surgical procedures or devices.
- Medical records research — uses historical information collected from medical records of large groups of people to study how diseases progress and which treatments and surgeries work best.
Study IDs
Site IRB
- Scottsdale/Phoenix, Arizona: 21-012217
NCT ID: NCT04505956
About this study
The purpose of this study is to evaluate the potential of Moses laser technology to reduce operative time compared to non-Moses settings for ureteroscopic treatment of nephrolithiasis.
Participation eligibility
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.
Inclusion Criteria:
- Participants must be 18 years or older.
- Must be a suitable operative candidate for flexible ureteroscopy as first line treatment for their renal stone as per accepted guidelines and as deemed by their urologic surgeon.
- Patients must additionally have a radiopaque solitary renal stone 8 to 20 mm in size or in the case of multiple stones, the conglomerate diameter (additive maximal diameter of all stones on axial imaging of computed tomography) of 8-20 mm is required.
- Must be able to give consent.
Exclusion Criteria:
- Participants with concomitant stones in the ureter.
- Patients who have had prior ipsilateral upper urinary tract reconstructive procedures or history of ipsilateral ureteral stricture will also be excluded.
- Patients who have undergone prior radiotherapy to the abdomen or pelvis and those who have a neurogenic bladder or spinal cord injury.
- Pregnant subjects.
- Patients with untreated UTI.
- Attending surgeons participating in the study at Mayo Clinic must be urological surgeons.
Eligibility last updated 11/19/21. Questions regarding updates should be directed to the study team contact.
Participating Mayo Clinic locations
Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.
| Mayo Clinic Location |
Status |
|
Scottsdale/Phoenix, Ariz.
Mayo Clinic principal investigator Karen Stern, M.D. |
Closed for enrollment |
|
More information
Publications
Publications are currently not available